Show simple item record

dc.contributor.authorDiez, P
dc.contributor.authorHanna, GG
dc.contributor.authorAitken, KL
dc.contributor.authorvan As, N
dc.contributor.authorCarver, A
dc.contributor.authorColaco, RJ
dc.contributor.authorConibear, J
dc.contributor.authorDunne, EM
dc.contributor.authorEaton, DJ
dc.contributor.authorFranks, KN
dc.contributor.authorGood, JS
dc.contributor.authorHarrow, S
dc.contributor.authorHatfield, P
dc.contributor.authorHawkins, MA
dc.contributor.authorJain, S
dc.contributor.authorMcDonald, F
dc.contributor.authorPatel, R
dc.contributor.authorRackley, T
dc.contributor.authorSanghera, P
dc.contributor.authorTree, A
dc.contributor.authorMurray, L
dc.date.accessioned2022-06-01T11:57:05Z
dc.date.available2022-06-01T11:57:05Z
dc.identifier.citationClinical oncology (Royal College of Radiologists (Great Britain)), 2022, 34 (5), pp. 288 - 300
dc.identifier.issn0936-6555
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5165
dc.identifier.eissn1433-2981
dc.identifier.doi10.1016/j.clon.2022.02.010
dc.description.abstractThe use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in part as the result of several UK clinical trials and a recent NHS England Commissioning through Evaluation programme. A UK SABR Consortium consensus for normal tissue constraints for SABR was published in 2017, based on the existing literature at the time. The published literature regarding SABR has increased in volume over the past 5 years and multiple UK centres are currently working to develop new SABR services. A review and update of the previous consensus is therefore appropriate and timely. It is hoped that this document will provide a useful resource to facilitate safe and consistent SABR practice.
dc.formatPrint-Electronic
dc.format.extent288 - 300
dc.languageeng
dc.language.isoeng
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserved
dc.subjectLung
dc.subjectHumans
dc.subjectCarcinoma, Hepatocellular
dc.subjectLiver Neoplasms
dc.subjectLung Neoplasms
dc.subjectRadiosurgery
dc.subjectConsensus
dc.subjectEngland
dc.titleUK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy.
dc.typeJournal Article
dcterms.dateAccepted2022-02-14
rioxxterms.versionAM
rioxxterms.versionofrecord10.1016/j.clon.2022.02.010
dc.relation.isPartOfClinical oncology (Royal College of Radiologists (Great Britain))
pubs.issue5
pubs.notesNot known
pubs.organisational-group/ICR
pubs.publication-statusPublished
pubs.volume34
pubs.embargo.termsNot known
dc.contributor.icrauthorTree, Alison


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record